Intranasally delivered fucoidan nanozyme–decorated photosynthetic Chlamydomonas regulates vascular pathology and hypoxia in diabetes-associated retinal microvascular dysfunction

Read full text Summarise with VIRAT
Authors: Andrew E-Y Chuang, Yo-Lin Chen, Chia‐Hung Liu, Hieu Trung Nguyen, Tsung-Jen Wang, I‐Chan Lin
Cited by: 0
References: 79

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Diabetic retinopathy (DR) is a leading cause of vision loss and is strongly associated with microvascular pathology and retinal hypoxia. Here, we report an intranasally delivered microalgae drug delivery system, Chlamydomonas@Pro-Fu-PEDOT nanozymes (CHL@Pro-Fu-PEDOT-NZs), engineered to target retinal injury. Under 660-nm red-light irradiation, the platform exploits the photosynthetic activity of Chlamydomonas to generate bioelectric cues and therapeutic gases (O 2 ), thereby alleviating hypoxia and reducing vascularization. Fucoidan functionalization further confers P-selectin–mediated vascular addressing, enabling lesion-focused delivery and regulation of hypoxia-driven vascular responses through photosynthesis-inspired gas generation and bioelectrical modulation. In vitro, CHL@Pro-Fu-PEDOT-NZs exhibited excellent biocompatibility and protected retinal ganglion cells from oxidative and inflammatory injury. In a streptozotocin (STZ)–induced DR mouse model, intranasal delivery mitigated pathological retinal responses, as evidenced by reduced VEGF and HIF-1α expression, and yielded measurable improvements in visual behavior, without detectable systemic toxicity. Collectively, this multifunctional, noninvasive therapeutic platform offers strong potential for DR treatment by simultaneously addressing vascular dysfunction, and hypoxia.

Fields of Study & Subjects

Retinal Diseases and Treatments Advanced Drug Delivery Systems Nanoplatforms for cancer theranostics

Publication details

Journal / source
Materials Today Bio
Volume
38
Pages
103060–103060
Publication date
26 March 2026
Language
EN